These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33032779)

  • 1. Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals.
    Pennington BM
    Value Health; 2020 Oct; 23(10):1349-1357. PubMed ID: 33032779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals.
    Tosh JC; Longworth LJ; George E
    Value Health; 2011 Jan; 14(1):102-9. PubMed ID: 21211492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Including carer health-related quality of life in NICE health technology assessments in the United Kingdom.
    Kanters TA; van Hezik-Wester V; Boateng A; Cranmer H; Kvamme I; Santi I; Al-Janabi H; van Exel J
    Health Econ Policy Law; 2024 Oct; ():1-13. PubMed ID: 39377220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY?
    Carroll C; Houten R; Boland A; Kaltenthaler E; Dickson R
    Value Health; 2018 Mar; 21(3):341-350. PubMed ID: 29566842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals.
    Pennington B; Hernandez-Alava M; Pudney S; Wailoo A
    Pharmacoeconomics; 2019 Jan; 37(1):75-84. PubMed ID: 30094806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Methods Used to Generate Utility Values in NICE Technology Assessments for Children and Adolescents.
    Hill H; Rowen D; Pennington B; Wong R; Wailoo A
    Value Health; 2020 Jul; 23(7):907-917. PubMed ID: 32762993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors.
    Chen G; Peirce V; Marsh W
    Value Health; 2020 Oct; 23(10):1300-1306. PubMed ID: 33032773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health state utilities associated with caring for an individual with cutaneous T-cell lymphoma (CTCL).
    Williams K; Gibson A; McNamara L; Jones T; Lloyd AJ
    J Med Econ; 2020 Oct; 23(10):1142-1150. PubMed ID: 32644862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit of data redaction practices in NICE technology appraisals from 1999 to 2019.
    Osipenko L
    BMJ Open; 2021 Oct; 11(10):e051812. PubMed ID: 34615680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review.
    Meregaglia M; Nicod E; Drummond M
    Eur J Health Econ; 2023 Sep; 24(7):1151-1216. PubMed ID: 36335234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves?
    Drummond MF; Iglesias CP; Cooper NJ
    Int J Technol Assess Health Care; 2008; 24(2):146-50. PubMed ID: 18400116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling Spillover Effects on Informal Carers: The Carer QALY Trap.
    Mott DJ; Schirrmacher H; Al-Janabi H; Guest S; Pennington B; Scheuer N; Shah KK; Skedgel C
    Pharmacoeconomics; 2023 Dec; 41(12):1557-1561. PubMed ID: 37659032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Adjustment Methods for Indirect Comparisons: A Review of National Institute for Health and Care Excellence Technology Appraisals.
    Phillippo DM; Dias S; Elsada A; Ades AE; Welton NJ
    Int J Technol Assess Health Care; 2019 Jan; 35(3):221-228. PubMed ID: 31190671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017.
    Gallacher D; Auguste P; Connock M
    Int J Technol Assess Health Care; 2019 Jan; 35(2):160-167. PubMed ID: 31017564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What value health?: A review of health state values used in early technology assessments for NICE.
    Stein K; Fry A; Round A; Milne R; Brazier J
    Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Cost-Utility Analyses That Have Included Carer and Family Member Health-Related Quality of Life.
    Scope A; Bhadhuri A; Pennington B
    Value Health; 2022 Sep; 25(9):1644-1653. PubMed ID: 35339379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalogue of EQ-5D scores for the United Kingdom.
    Sullivan PW; Slejko JF; Sculpher MJ; Ghushchyan V
    Med Decis Making; 2011; 31(6):800-4. PubMed ID: 21422468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the National Institute for Health and Care Excellence Severity Premium: Exploring Its Implementation and the Implications for Decision Making and Patient Access.
    Njoroge MW; Walton M; Hodgson R
    Value Health; 2024 Jun; 27(6):730-736. PubMed ID: 38447743
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.